Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Saama Technologies Announces Appointment of New CEO Vivek Sharma

    Jun 30, 2022, 09:17 AM by
    #1 AI clinical analytics platform company Saama Technologies welcomes global life sciences industry expert Vivek Sharma as new CEO
    Full story
  • Kyruus Announces Paul Merrild as Company’s First President

    Jun 30, 2022, 09:15 AM by
    Leadership Team Expansion Follows Year of Accelerated Growth
    Full story
  • PHASTAR Names Chris Schoonmaker as Chief Operations Officer

    Jun 30, 2022, 09:14 AM by
    PHASTAR Names Chris Schoonmaker as Chief Operations Officer  London, UK and Durham, NC - June 29, 2022 – PHASTAR, a global specialist biometrics contract research organization (CRO) offering industry leading data management, data science, statistical consulting, and clinical trial reporting services, today announces that Chris Schoonmaker has joined the company as Chief Operations Officer. Chris will direct PHASTAR’s operational strategy with a key focus on ensuring quality deliverables and providing a positive customer experience.
    Full story
  • Remote AI-Run Robotics Lab, Gut Microbiome as Targetable Biomarker, More

    Jun 30, 2022, 01:00 AM by User Not Found
    Bio-IT World | A comprehensive ligand- and structure-based design platform delivers new and improved features for molecule design; an advanced automated GC headspace sampler and GC/mass spectrometry solution helps lab teams simplify operations; 10x Genomics releases a series of profiling products; and more.
    Full story
  • Alzheimer’s Disease Diagnostic Market – Global Industry Size, Trends and COVID-19 Impact Analysis (2022 to 2028)

    Jun 29, 2022, 09:18 AM by
    Full story
  • Sharp Adds New Talent in Global Operations and Finance to Senior Leadership Team

    Jun 29, 2022, 09:16 AM by
    Full story
  • Citeline and Norstella Unite to Offer Life Sciences Clients a Full Suite of Commercial and Clinical Solutions

    Jun 29, 2022, 09:15 AM by
    Citeline and Norstella Unite to create a new organization that will help life sciences companies improve strategic decision-making and accelerate the mission of smoothing access to therapy from pipeline to patient
    Full story
  • BOC Sciences Demonstrates Comprehensive Strength with LYTAC Technology

    Jun 29, 2022, 09:15 AM by
    BOC Sciences demonstrates its comprehensive strength with innovative LYTAC degradation technology solutions developed in the field of targeted protein degradation.
    Full story
  • One-stop Mitochondria-focused Testing Services Targeting to Preclinical Studies of Cardiac Diseases

    Jun 29, 2022, 09:14 AM by
    Creative Biogene offers one-stop mitochondria-focused testing services for the evaluation of a variety of cardiac diseases associated with mitochondrial dysfunction.
    Full story
  • Follow the Money: Drug Discovery Robotics Lab, Clinical Sequencing Platform, More

    Jun 29, 2022, 01:00 AM by User Not Found
    Bio-IT World | Funding for single-cell sequencing, small molecule drug discovery, neurological biomarkers, and more.
    Full story
  • MMS Holdings Partners with Lindsay Goldberg for Its Next Stage of Growth

    Jun 28, 2022, 09:23 AM by
    MMS Holdings, a contract research organization, announced today that Lindsay Goldberg, a private equity firm, has completed an investment in the company. The partnership will help MMS expand its data-focused clinical research services.
    Full story
  • Creative Proteomics Cytokine Boosts Your Research and Discovery with Mouse Cytokine Assay

    Jun 28, 2022, 09:18 AM by
    Full story
  • Creative Proteomics Lipidomics Introduces Glycerophospholipids Analysis Service

    Jun 28, 2022, 09:17 AM by
    Full story
  • Creative Proteomics Metabolomics Expands Service Offering with the Launch of Food Metabolomics Service

    Jun 28, 2022, 09:16 AM by
    Full story
  • ‘My Healthy Maryland’ Study Launches on Vibrent Health Platform, Using Next-Generation Digital Research Tools to Create Biggest and Most Diverse Health Database in State

    Jun 28, 2022, 09:15 AM by
    University of Maryland Medicine Precision Health Study Utilizes Vibrent Health’s Accessible and Scalable Online Platform with a Goal to Enroll 250,000 Diverse Maryland Residents to Learn How Genes and Other Factors Affect Health
    Full story
  • Susan Gregurick Previews Potential Elements of NIH’s Next Strategic Plan for Data Science

    Jun 28, 2022, 01:00 AM by User Not Found
    Bio-IT World | In the latest episode of Bio-IT World’s Trends from the Trenches podcast, Susan Gregurick, Associate Director for Data Science and Director of the Office of Data Science Strategy at the National Institutes of Health, gave a peek into what’s coming in the next iteration of the NIH Strategic Plan for Data Science.
    Full story
  • Cotiviti to Share Expertise on the Role of Quality in Improving Healthcare Outcomes at RISE Qualipalooza Conference

    Jun 27, 2022, 10:48 AM by
    Senior Vice President Rachael Jones to co-chair RISE event focused on improving quality of care and member experience
    Full story
  • ObvioHealth announces a groundbreaking partnership with Dedalus Group to unite real world & clinical trial data

    Jun 27, 2022, 10:48 AM by
    ObvioHealth, a global virtual research organization (VRO), is bringing clinical trial data fully into the continuum of care through a new strategic partnership with Dedalus Group, the leading healthcare and diagnostic software solutions provider in Europe.
    Full story
  • Novel PTSD Treatment Advances Toward Regulatory Evaluation with New Collaboration Between MAPS PBC and MMS Holdings

    Jun 27, 2022, 10:48 AM by
    On PTSD Awareness Day, MAPS PBC announces plans to develop the New Drug Application for MDMA-assisted therapy in collaboration with MMS Holdings The second Phase 3 trial of the Breakthrough-Designated Therapy for PTSD will be completed in late 2022, with a targeted NDA submission in 2023 supported by MMS Holdings MMS Holdings, which specializes in supporting first-in-class NDAs, was selected for extensive experience in neuroscience
    Full story
  • MicrobioSeq Boosts Microbial Diversity Research with Eukaryotic 18S rRNA Sequencing

    Jun 27, 2022, 10:47 AM by
    Full story
  • «
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139 (current)
  • 140
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy